TIGIT and non-small cell lung carcinoma: Meanwhile, the expression of TIGIT in the high-risk group of NSCLC patients with radiotherapy was significantly higher than that in the low-risk group (P < 0.05) (Figure 4(d)), implying that immunosuppressive microenvironment might contribute to the poor prognosis of NSCLC patients with radiotherapy.